Arcturus Therapeutics Public Market Comparables
Find the most relevant public market comparables for Arcturus Therapeutics, including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Arcturus Therapeutics is a commercial mRNA medicines and vaccines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. They utilize proprietary lipid-mediated delivery systems (LUNAR®) and STARR® mRNA technology (sa-mRNA) for the discovery, development, and commercialization of mRNA medicines for rare and infectious diseases.
Business Model
Discovery, development, and commercialization of mRNA medicines and vaccines.
Target Customers
Patients with rare diseases (e.g., ornithine transcarbamylase deficiency, cystic fibrosis), and the general population for infectious disease vaccines (e.g., COVID-19, influenza).
Specific Focus
mRNA medicines and vaccines, particularly self-amplifying mRNA (sa-mRNA) technology for infectious diseases and rare diseases.
Location
San Diego, California
CEO
Joseph E. Payne
Industry
Life sciences
Sub Sector
RNA Therapeutics
3yr Revenue Growth
1,554%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Arcturus Therapeutics in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Arcturus Therapeutics? Our platform provides detailed analysis of Arcturus Therapeutics's competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Arcturus Therapeutics compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Arcturus Therapeutics Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Arcturus Therapeutics operates in the specialized RNA Therapeutics sub-sector. Understanding how Arcturus Therapeutics compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the RNA Therapeutics space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Moderna
Biotechnology • Life sciences
Moderna is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines. They develop and discover drugs that produce proteins or antibodies inside patient cells, focusing on areas such as infectious diseases, rare liver disease, immuno-oncology, and cardiovascular disease. Their mRNA platform produces human proteins, antibodies, and novel proteins to prevent, treat, and cure diseases.
Catalyst Pharmaceuticals, Inc.
Health Care • Life sciences
A commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients with rare and difficult-to-treat diseases.
TailorMed Medical
Healthcare Technology • Software & services
TailorMed is a healthcare technology company focused on improving the financial performance of healthcare providers and reducing financial hardship for patients. The company's platform matches patients with financial assistance programs offered by drug companies, helping patients afford medications and driving higher revenues for providers. TailorMed offers a comprehensive suite of products to automate the process of identifying and enrolling patients in financial assistance programs, including a powerful analytics and reporting dashboard, and a free/replacement drug program.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Arcturus Therapeutics and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free